Literature DB >> 16571861

Visceral fat is an independent predictor of all-cause mortality in men.

Jennifer L Kuk1, Peter T Katzmarzyk, Milton Z Nichaman, Timothy S Church, Steven N Blair, Robert Ross.   

Abstract

OBJECTIVE: To examine the independent associations of abdominal fat (visceral and subcutaneous) and liver fat with all-cause mortality. RESEARCH METHODS AND PROCEDURES: Participants included 291 men [97 decedents and 194 controls; mean age, 56.4 +/- 12.0 (SD) years] who received a computed tomography (CT) examination at the preventive medicine clinic in Dallas, TX, between 1995 and 1999, with a mean mortality follow-up of 2.2 +/- 1.3 years. Abdominal fat was determined using contiguous CT images from the L3-L4 to L4-L5 intervertebral space. Liver fat was assessed using the CT-determined liver attenuation value, which is inversely related to liver fat. Logistic regression was used to determine the independent association between the fat depots and all-cause mortality.
RESULTS: During the study, there were 97 deaths. Visceral fat [odds ratio (OR) per SD: 1.83; 95% CI: 1.23 to 2.73], abdominal subcutaneous fat (1.44; 1.02 to 2.03), liver fat (0.64; 0.46 to 0.87), and waist circumference (1.41; 1.01 to 1.98) were significant individual predictors of mortality after controlling for age and length of follow-up. In a model including all three fat measures (subcutaneous, visceral, and liver fat), age, and length of follow-up, only visceral fat (1.93; 1.15 to 3.23) was a significant predictor of mortality. DISCUSSION: Visceral fat is a strong, independent predictor of all-cause mortality in men.

Entities:  

Mesh:

Year:  2006        PMID: 16571861     DOI: 10.1038/oby.2006.43

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  187 in total

1.  Treating diet-induced obesity: a new role for vagal afferents?

Authors:  Edward A Fox
Journal:  Dig Dis Sci       Date:  2012-03-22       Impact factor: 3.199

2.  Significant associations of age, menopausal status and lifestyle factors with visceral adiposity in African-American and European-American women.

Authors:  Ellen W Demerath; Nikki L Rogers; Derek Reed; Miryoung Lee; Audrey C Choh; Roger M Siervogel; Wm Cameron Chumlea; Bradford Towne; Stefan A Czerwinski
Journal:  Ann Hum Biol       Date:  2010-12-22       Impact factor: 1.533

3.  Muscle area and density and risk of all-cause mortality: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Britta Larsen; John Bellettiere; Matthew Allison; Robyn L McClelland; Iva Miljkovic; Chantal A Vella; Pamela Ouyang; Kimberly R De-Guzman; Michael Criqui; Jonathan Unkart
Journal:  Metabolism       Date:  2020-07-23       Impact factor: 8.694

4.  Nonalcoholic fatty liver disease is associated with coronary artery calcification.

Authors:  Donghee Kim; Su-Yeon Choi; Eun Ha Park; Whal Lee; Jin Hwa Kang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sook Hyang Jeong; Dong Ho Lee; Hyo-suk Lee; Joseph Larson; Terry M Therneau; W Ray Kim
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

5.  Computed tomography-defined abdominal adiposity is associated with acute kidney injury in critically ill trauma patients*.

Authors:  Michael G S Shashaty; Esra Kalkan; Scarlett L Bellamy; John P Reilly; Daniel N Holena; Kathleen Cummins; Paul N Lanken; Harold I Feldman; Muredach P Reilly; Jayaram K Udupa; Jason D Christie
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

6.  Total and regional adiposity measured by dual-energy X-ray absorptiometry and mortality in NHANES 1999-2006.

Authors:  Geng Zong; Zefeng Zhang; Quanhe Yang; Hongyu Wu; Frank B Hu; Qi Sun
Journal:  Obesity (Silver Spring)       Date:  2016-09-26       Impact factor: 5.002

7.  Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation.

Authors:  Naima Covassin; Fatima H Sert-Kuniyoshi; Prachi Singh; Abel Romero-Corral; Diane E Davison; Francisco Lopez-Jimenez; Michael D Jensen; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2018-05       Impact factor: 7.616

Review 8.  Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment.

Authors:  Jordan Gaines; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2018-09-03       Impact factor: 11.609

Review 9.  Gender differences in obstructive sleep apnea and treatment implications.

Authors:  Christine M Lin; Terence M Davidson; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2008-10-31       Impact factor: 11.609

10.  Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels.

Authors:  Ellen W Demerath; Derek Reed; Nikki Rogers; Shumei S Sun; Miryoung Lee; Audrey C Choh; William Couch; Stefan A Czerwinski; W Cameron Chumlea; Roger M Siervogel; Bradford Towne
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.